LLY

1,109.44

+0.48%↑

JNJ

239.41

+3.6%↑

ABBV

234.8

+2.18%↑

UNH

409.32

+0.85%↑

NVS

153.4

+3.33%↑

LLY

1,109.44

+0.48%↑

JNJ

239.41

+3.6%↑

ABBV

234.8

+2.18%↑

UNH

409.32

+0.85%↑

NVS

153.4

+3.33%↑

LLY

1,109.44

+0.48%↑

JNJ

239.41

+3.6%↑

ABBV

234.8

+2.18%↑

UNH

409.32

+0.85%↑

NVS

153.4

+3.33%↑

LLY

1,109.44

+0.48%↑

JNJ

239.41

+3.6%↑

ABBV

234.8

+2.18%↑

UNH

409.32

+0.85%↑

NVS

153.4

+3.33%↑

LLY

1,109.44

+0.48%↑

JNJ

239.41

+3.6%↑

ABBV

234.8

+2.18%↑

UNH

409.32

+0.85%↑

NVS

153.4

+3.33%↑

Search

Bausch Health Cos Inc

Fermé

SecteurSoins de santé

4.79 3.01

Résumé

Variation du prix de l'action

24h

Actuel

Min

4.64

Max

4.79

Chiffres clés

By Trading Economics

Revenu

-1.3B

-1.4B

Ventes

-350M

2.5B

P/E

Moyenne du Secteur

13.286

49.712

BPA

0.78

Marge bénéficiaire

-57.492

Employés

20,300

EBITDA

-1.3B

-648M

Recommandations

By TipRanks

Recommandations

Neutre

Prévisions sur 12 Mois

+60.8% upside

Dividendes

By Acuity

Prochains Résultats

29 juil. 2026

Statistiques du Marché

By TradingEconomics

Capitalisation Boursière

-220M

1.9B

Ouverture précédente

1.78

Clôture précédente

4.79

Sentiment de l'Actualité

By Acuity

62%

38%

278 / 342 Classement par Healthcare

Bausch Health Cos Inc Graphique

Les performances passées ne sont pas un indicateur fiable des résultats futurs.

À Propos Bausch Health Cos Inc

Bausch Health Companies Inc. operates as a diversified specialty pharmaceutical and medical device company in the United States and internationally. It develops, manufactures, and markets a range of products primarily in gastroenterology, hepatology, neurology, dermatology, international pharmaceuticals, over-the-counter (OTC) products, aesthetic medical devices, and eye health. The company operates through five segments: Salix, International, Solta Medical, Diversified, and Bausch + Lomb. The Salix segment provides gastroenterology products in the United States. The International segment sells aesthetic medical devices, branded pharmaceuticals, generic pharmaceuticals, and OTC products internationally. The Solta Medical segment engages in the sale of aesthetic medical devices. The Diversified segment offers pharmaceutical products in the areas of neurology and certain other therapeutic classes; generic products; ortho dermatologic; and dentistry products in the United States. The Bausch + Lomb segment offers products in the areas of vision care, surgical, and ophthalmic pharmaceuticals products. The company was formerly known as Valeant Pharmaceuticals International, Inc. and changed its name to Bausch Health Companies Inc. in July 2018. Bausch Health Companies Inc. is headquartered in Laval, Canada.
help-icon Live chat